Hepatocellular Carcinoma and Antiviral Therapies in HCV Chronic Infection
The development of direct-acting antiviral (DAA) therapies in chronic HCV infection has been associated with increased expectations regarding the prognosis of this infection in the medical community, as the possibility of HCV eradication is now in sight. While the cure of the HVC infection has been...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/75455 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Hepatocellular Carcinoma and Antiviral Therapies in HCV Chronic Infection
- Antiviral Therapy in HCV-Infected Decompensated Cirrhotics
- Dyslipoproteinemia in Chronic HCV Infection
- Treatment of Chronic HCV Infection in the Era of Protease Inhibitors
- Systemic Therapy in Hepatocellular Carcinoma
- Targeted Therapies for Hepatocellular Carcinoma Treatment
- Flaviviral Infections and Potential Targets for Antiviral Therapy